[Actual evaluation of pharmacologic treatment for benign changes in the prostate gland (prostate:lrs)].
Dutkiewicz
S
S
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D042944:Cholestenone 5 alpha-Reductase; D017292:Doxazosin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010088:Oxidoreductases / Q000037:antagonists & inhibitors; D011470:Prostatic Hyperplasia / Q000188:drug therapy*
D000317:Adrenergic alpha-Antagonists; D010088:Oxidoreductases; D042944:Cholestenone 5 alpha-Reductase; D017292:Doxazosin